title: Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, CHU Pitié Salpetriere, Paris, France.
authors.forename: R
authors.initials: R
authors.lastname: Dorent
authors.forename: A
authors.initials: A
authors.lastname: Pavie
authors.forename: P
authors.initials: P
authors.lastname: Nataf
authors.forename: G
authors.initials: G
authors.lastname: Tedy
authors.forename: E
authors.initials: E
authors.lastname: Vaissier
authors.forename: J J
authors.initials: JJ
authors.lastname: Ghoussoub
authors.forename: V
authors.initials: V
authors.lastname: Bors
authors.forename: I
authors.initials: I
authors.lastname: Gandjbakhch
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000139:chemically induced / Q000601:surgery*; D016572:Cyclosporine / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D016027:Heart Transplantation / Q000276:immunology / Q000401:mortality; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D015996:Survival Rate
chemical_list: D004317:Doxorubicin; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D003630:Daunorubicin